Article
Weighing the risks when complications may be significant
Harrow to enact a 5-year strategic supply and development agreement for triamcinolone acetonide injectable suspension
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Ophthalmology sees AI-powered impact on cataract and diabetic eye disease
(EyePod) From idea to impact: Navigating ophthalmic innovation
Alcon announces US launch of Voyager direct selective laser trabeculoplasty device
510(k) clearance issued by FDA for the VIA360 Surgical System by New World Medical
